Gut microbiota, low-grade inflammation, and metabolic syndrome.
about
Nutrition facts in multiple sclerosisEnvironmental factors in autoimmune diseases and their role in multiple sclerosisRole of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic SyndromeColonic Microbiota Encroachment Correlates With Dysglycemia in HumansGut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.16S gut community of the Cameron County Hispanic Cohort.Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetesThe intestinal microbiota: its role in health and disease.Commensal Streptococcus salivarius Modulates PPARγ Transcriptional Activity in Human Intestinal Epithelial Cells.Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts.Innate immune responses to gut microbiota differ between oceanic and freshwater threespine stickleback populations.Has provoking microbiota aggression driven the obesity epidemic?Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphataseXylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot studyGut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization.Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvención con DIeta MEDiterránea) trialChange in gut microbiota is correlated with alterations in the surface molecule expression of monocytes after Roux-en-Y gastric bypass surgery in obese type 2 diabetic patientsThe role of diet in multiple sclerosis: A review.Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis.Role of vitamin D on gut microbiota in cystic fibrosis.Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease.Insights on the impact of diet-mediated microbiota alterations on immunity and diseases.Early intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment.Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome.Polyphenol- and caffeine-rich post-fermented Pu-er tea improves diet-induced metabolic syndrome by remodeling intestinal homeostasis in mice.Effects of Antidiabetic Drugs on Gut Microbiota Composition.The Maternal Gut Microbiome During Pregnancy.Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon.Studying microbial functionality within the gut ecosystem by systems biology.Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota.Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity.Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndromeDoes Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
P2860
Q26851247-904B2F73-D3B6-4D56-949D-4230EDBF4828Q28078461-9DBD5836-D137-4694-96D9-83D5CD962BE6Q28315036-386673BD-11F6-4FBB-92DA-DD14BC405ACCQ33802989-CB684AF0-9BE4-46E3-A3AA-31F73983C1ADQ34499017-9AA8D859-F47C-4F75-ACED-A9EE1BF600D4Q35166491-D7D958FD-AEF2-4298-A41E-5E5919E21B35Q35167112-C5C72E20-EB2F-4D77-954E-C59DCF8CFCAAQ35538922-626CF7D4-2E40-4543-B369-ABE34507EC2AQ35623144-AA8A10EA-E614-4A12-AC23-8C8DAB1C09E3Q35765629-49F2A773-70A0-4658-8CDA-8F2C37B125F8Q35872737-30F74C1B-CD92-40FA-B7E8-42D438E1B7ACQ35889587-A6970C2D-B9B1-45AE-BB38-1B340A303E97Q35923655-59697194-9E28-48F9-971C-EE577D00A758Q35926238-2397C978-618B-47BD-B248-A9FD4495F0ECQ36196897-9622EA1C-D05E-4764-92FF-05CDDE3FECABQ36909148-2B10CB67-8395-4517-BF13-3B23A65406DEQ37733018-75CEA576-2F18-4304-94A7-A0C73FE51E88Q38740469-61819EC4-5680-4B78-9B12-969C656BA5BDQ38750137-9ED9E674-73AA-4C17-9C85-7924E0EC0B49Q38798347-AB30CDBD-8676-4E17-9D40-9DA4FFC98877Q39000441-B6409F30-1FA2-4173-8531-A9EF248C7F8BQ39078650-433C6396-481F-4D9F-B236-15277ED88367Q40072807-6B0717ED-0DD2-4402-B9A8-FB3EB6FC2EA5Q40135366-A2424940-8348-4FE6-BDAF-416FAF5E5272Q40460894-71762639-E004-498B-93EE-125713D895A0Q46257613-B6EA6E7D-D5E4-4904-85FB-FDFF6E577865Q46276944-64B8112E-E580-4BD4-9DF2-AD364D90C391Q46295791-D5E597F7-1AF5-4CEB-8B78-DCAEF24CC75EQ46324181-E543CB84-A2BE-4FF6-9FE7-A42E2B9767C4Q47138517-6C9E75DC-293D-4E14-8816-4ED8F39412B1Q51146477-08E7E8F3-335C-466D-9046-2B4C4B30A4A4Q52682415-B1057E0A-EBE4-4499-BA1B-BA271E270246Q53174998-2E441D94-0536-4C78-B638-8194D3E04567Q58577724-9DEB144B-8C1D-4F7B-999D-E759E03A1EC4Q58777287-1020D6B1-54CD-4962-9923-71C2944D0DA7
P2860
Gut microbiota, low-grade inflammation, and metabolic syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@ast
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@en
type
label
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@ast
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@en
prefLabel
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@ast
Gut microbiota, low-grade inflammation, and metabolic syndrome.
@en
P2860
P356
P1476
Gut microbiota, low-grade inflammation, and metabolic syndrome
@en
P2093
Andrew T Gewirtz
P2860
P356
10.1177/0192623313508481
P407
P577
2013-11-27T00:00:00Z